Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes

Pancreatic islet transplantation is a rapidly evolving field. It has been increasingly regarded as a promising approach for the correction of dysglycemia associated with type 1 diabetes mellitus (allogenic islet transplantation), or the prevention of surgical diabetes in chronic pancreatitis subject...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Khawla F., Hatipoglu, Betul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409867/
https://www.ncbi.nlm.nih.gov/pubmed/32775966
http://dx.doi.org/10.21926/obm.transplant.2003115
_version_ 1783568141221101568
author Ali, Khawla F.
Hatipoglu, Betul
author_facet Ali, Khawla F.
Hatipoglu, Betul
author_sort Ali, Khawla F.
collection PubMed
description Pancreatic islet transplantation is a rapidly evolving field. It has been increasingly regarded as a promising approach for the correction of dysglycemia associated with type 1 diabetes mellitus (allogenic islet transplantation), or the prevention of surgical diabetes in chronic pancreatitis subjects undergoing total pancreatectomy (autologous islet transplantation). In this review, we discuss the latest literature pertaining to metabolic outcomes of autologous and allogenic islet transplantation, shedding close light on our own latest experience in the autologous islet transplantation setting.
format Online
Article
Text
id pubmed-7409867
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-74098672020-08-06 Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes Ali, Khawla F. Hatipoglu, Betul OBM Transplant Article Pancreatic islet transplantation is a rapidly evolving field. It has been increasingly regarded as a promising approach for the correction of dysglycemia associated with type 1 diabetes mellitus (allogenic islet transplantation), or the prevention of surgical diabetes in chronic pancreatitis subjects undergoing total pancreatectomy (autologous islet transplantation). In this review, we discuss the latest literature pertaining to metabolic outcomes of autologous and allogenic islet transplantation, shedding close light on our own latest experience in the autologous islet transplantation setting. 2020-07-07 2020 /pmc/articles/PMC7409867/ /pubmed/32775966 http://dx.doi.org/10.21926/obm.transplant.2003115 Text en This is an open access article distributed under the conditions of the Creative Commons by Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is correctly cited.
spellingShingle Article
Ali, Khawla F.
Hatipoglu, Betul
Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes
title Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes
title_full Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes
title_fullStr Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes
title_full_unstemmed Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes
title_short Pancreatic Islet Cell Transplantation: Graft Stability and Metabolic Outcomes
title_sort pancreatic islet cell transplantation: graft stability and metabolic outcomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409867/
https://www.ncbi.nlm.nih.gov/pubmed/32775966
http://dx.doi.org/10.21926/obm.transplant.2003115
work_keys_str_mv AT alikhawlaf pancreaticisletcelltransplantationgraftstabilityandmetabolicoutcomes
AT hatipoglubetul pancreaticisletcelltransplantationgraftstabilityandmetabolicoutcomes

Ejemplares similares